Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020

As at 27 January 2020, 42 novel coronavirus (2019-nCoV) cases were confirmed outside China. We estimate the risk of case importation to Europe from affected areas in China via air travel. We consider travel restrictions in place, three reported cases in France, one in Germany. Estimated risk in Europe remains high. The United Kingdom, Germany and France are at highest risk. Importation from Beijing and Shanghai would lead to higher and widespread risk for Europe.

Keywords

2019-nCoV Europe importation risk travel ban

Domains

Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Human health and pathology Emerging diseases Life Sciences [q-bio] Santé publique et épidémiologie

Fichier principal

eurosurv-25-4-1.pdf (1.97 Mo)

Origin : Publication funded by an institution

Myriam Bodescot : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02517345

Submitted on : Tuesday, March 24, 2020-2:59:47 PM

Last modification on : Tuesday, November 29, 2022-12:06:07 PM

Dates and versions

inserm-02517345 , version 1 (24-03-2020)

Identifiers

HAL Id : inserm-02517345 , version 1
DOI : 10.2807/1560-7917.ES.2020.25.4.2000057
PUBMED : 32019667
PUBMEDCENTRAL : PMC7001240

Cite

Giulia Pullano, Francesco Pinotti, Eugenio Valdano, Pierre-Yves Boëlle, Chiara Poletto, et al.. Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020. Eurosurveillance, 2020, 25 (4), ⟨10.2807/1560-7917.ES.2020.25.4.2000057⟩. ⟨inserm-02517345⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM IPLESP SORBONNE-UNIVERSITE SU-MEDECINE

240 View

158 Download